nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CYP2C9—Methimazole—Graves' disease	0.236	0.401	CbGbCtD
Celecoxib—CYP2D6—Methimazole—Graves' disease	0.216	0.366	CbGbCtD
Celecoxib—CYP3A4—Methimazole—Graves' disease	0.137	0.233	CbGbCtD
Celecoxib—Ageusia—Methimazole—Graves' disease	0.0113	0.0538	CcSEcCtD
Celecoxib—Ageusia—Propylthiouracil—Graves' disease	0.00964	0.0458	CcSEcCtD
Celecoxib—Aplastic anaemia—Methimazole—Graves' disease	0.00863	0.0409	CcSEcCtD
Celecoxib—PDPK1—pituitary gland—Graves' disease	0.00815	0.103	CbGeAlD
Celecoxib—PDPK1—adipose tissue—Graves' disease	0.00812	0.103	CbGeAlD
Celecoxib—Vasculitis—Propylthiouracil—Graves' disease	0.008	0.038	CcSEcCtD
Celecoxib—Aplastic anaemia—Propylthiouracil—Graves' disease	0.00733	0.0348	CcSEcCtD
Celecoxib—PDPK1—thyroid gland—Graves' disease	0.00703	0.0888	CbGeAlD
Celecoxib—Hepatic failure—Propylthiouracil—Graves' disease	0.00631	0.03	CcSEcCtD
Celecoxib—Renal failure acute—Propylthiouracil—Graves' disease	0.00614	0.0292	CcSEcCtD
Celecoxib—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.00601	0.0285	CcSEcCtD
Celecoxib—MAPK14—connective tissue—Graves' disease	0.00566	0.0715	CbGeAlD
Celecoxib—Neuropathy peripheral—Methimazole—Graves' disease	0.00504	0.0239	CcSEcCtD
Celecoxib—Jaundice—Methimazole—Graves' disease	0.00501	0.0238	CcSEcCtD
Celecoxib—Agranulocytosis—Methimazole—Graves' disease	0.0048	0.0228	CcSEcCtD
Celecoxib—PDPK1—CTLA4 inhibitory signaling—CTLA4—Graves' disease	0.00469	0.0391	CbGpPWpGaD
Celecoxib—Hepatitis—Methimazole—Graves' disease	0.00461	0.0219	CcSEcCtD
Celecoxib—CA12—eye—Graves' disease	0.00446	0.0563	CbGeAlD
Celecoxib—MAPK14—pituitary gland—Graves' disease	0.00436	0.0551	CbGeAlD
Celecoxib—MAPK14—adipose tissue—Graves' disease	0.00434	0.0549	CbGeAlD
Celecoxib—CA12—connective tissue—Graves' disease	0.00429	0.0542	CbGeAlD
Celecoxib—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00428	0.0203	CcSEcCtD
Celecoxib—Jaundice—Propylthiouracil—Graves' disease	0.00426	0.0202	CcSEcCtD
Celecoxib—Agranulocytosis—Propylthiouracil—Graves' disease	0.00408	0.0194	CcSEcCtD
Celecoxib—Alopecia—Methimazole—Graves' disease	0.00408	0.0194	CcSEcCtD
Celecoxib—Haemoglobin—Propylthiouracil—Graves' disease	0.00394	0.0187	CcSEcCtD
Celecoxib—Haemorrhage—Propylthiouracil—Graves' disease	0.00392	0.0186	CcSEcCtD
Celecoxib—Hepatitis—Propylthiouracil—Graves' disease	0.00392	0.0186	CcSEcCtD
Celecoxib—MAPK14—thyroid gland—Graves' disease	0.00376	0.0475	CbGeAlD
Celecoxib—Vertigo—Methimazole—Graves' disease	0.00361	0.0171	CcSEcCtD
Celecoxib—Leukopenia—Methimazole—Graves' disease	0.00359	0.0171	CcSEcCtD
Celecoxib—Alopecia—Propylthiouracil—Graves' disease	0.00347	0.0165	CcSEcCtD
Celecoxib—Arthralgia—Methimazole—Graves' disease	0.00342	0.0162	CcSEcCtD
Celecoxib—Myalgia—Methimazole—Graves' disease	0.00342	0.0162	CcSEcCtD
Celecoxib—Dysgeusia—Propylthiouracil—Graves' disease	0.00334	0.0159	CcSEcCtD
Celecoxib—Oedema—Methimazole—Graves' disease	0.00328	0.0156	CcSEcCtD
Celecoxib—Thrombocytopenia—Methimazole—Graves' disease	0.00321	0.0152	CcSEcCtD
Celecoxib—Vertigo—Propylthiouracil—Graves' disease	0.00307	0.0146	CcSEcCtD
Celecoxib—Leukopenia—Propylthiouracil—Graves' disease	0.00306	0.0145	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00299	0.0142	CcSEcCtD
Celecoxib—CA5B—adipose tissue—Graves' disease	0.00296	0.0373	CbGeAlD
Celecoxib—Paraesthesia—Methimazole—Graves' disease	0.00294	0.014	CcSEcCtD
Celecoxib—Somnolence—Methimazole—Graves' disease	0.00291	0.0138	CcSEcCtD
Celecoxib—Myalgia—Propylthiouracil—Graves' disease	0.00291	0.0138	CcSEcCtD
Celecoxib—Arthralgia—Propylthiouracil—Graves' disease	0.00291	0.0138	CcSEcCtD
Celecoxib—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SCGB3A2—Graves' disease	0.0029	0.0242	CbGpPWpGaD
Celecoxib—Dyspepsia—Methimazole—Graves' disease	0.00289	0.0137	CcSEcCtD
Celecoxib—Oedema—Propylthiouracil—Graves' disease	0.00279	0.0132	CcSEcCtD
Celecoxib—PDPK1—CXCR3-mediated signaling events—CXCL10—Graves' disease	0.00275	0.0229	CbGpPWpGaD
Celecoxib—PDPK1—TSH signaling pathway—TSHR—Graves' disease	0.00274	0.0228	CbGpPWpGaD
Celecoxib—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00273	0.013	CcSEcCtD
Celecoxib—Urticaria—Methimazole—Graves' disease	0.0026	0.0124	CcSEcCtD
Celecoxib—Body temperature increased—Methimazole—Graves' disease	0.00259	0.0123	CcSEcCtD
Celecoxib—CA5B—thyroid gland—Graves' disease	0.00256	0.0323	CbGeAlD
Celecoxib—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00254	0.0121	CcSEcCtD
Celecoxib—Paraesthesia—Propylthiouracil—Graves' disease	0.0025	0.0119	CcSEcCtD
Celecoxib—Somnolence—Propylthiouracil—Graves' disease	0.00248	0.0118	CcSEcCtD
Celecoxib—Dyspepsia—Propylthiouracil—Graves' disease	0.00245	0.0116	CcSEcCtD
Celecoxib—PDPK1—Downstream TCR signaling—HLA-DQB1—Graves' disease	0.00235	0.0196	CbGpPWpGaD
Celecoxib—PDPK1—FAS (CD95) signaling pathway—FASLG—Graves' disease	0.00234	0.0195	CbGpPWpGaD
Celecoxib—Pruritus—Methimazole—Graves' disease	0.00232	0.011	CcSEcCtD
Celecoxib—CA2—eye—Graves' disease	0.00229	0.0289	CbGeAlD
Celecoxib—PDPK1—FAS (CD95) signaling pathway—FAS—Graves' disease	0.00226	0.0188	CbGpPWpGaD
Celecoxib—ABCC4—adipose tissue—Graves' disease	0.00222	0.028	CbGeAlD
Celecoxib—PDPK1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00222	0.0185	CbGpPWpGaD
Celecoxib—Urticaria—Propylthiouracil—Graves' disease	0.00221	0.0105	CcSEcCtD
Celecoxib—CA2—connective tissue—Graves' disease	0.0022	0.0278	CbGeAlD
Celecoxib—Body temperature increased—Propylthiouracil—Graves' disease	0.0022	0.0105	CcSEcCtD
Celecoxib—Vomiting—Methimazole—Graves' disease	0.00208	0.00989	CcSEcCtD
Celecoxib—Rash—Methimazole—Graves' disease	0.00207	0.00981	CcSEcCtD
Celecoxib—Dermatitis—Methimazole—Graves' disease	0.00206	0.0098	CcSEcCtD
Celecoxib—Headache—Methimazole—Graves' disease	0.00205	0.00975	CcSEcCtD
Celecoxib—CA4—pituitary gland—Graves' disease	0.00205	0.0259	CbGeAlD
Celecoxib—CA4—adipose tissue—Graves' disease	0.00204	0.0258	CbGeAlD
Celecoxib—Pruritus—Propylthiouracil—Graves' disease	0.00197	0.00936	CcSEcCtD
Celecoxib—Nausea—Methimazole—Graves' disease	0.00195	0.00924	CcSEcCtD
Celecoxib—ABCC4—thyroid gland—Graves' disease	0.00192	0.0243	CbGeAlD
Celecoxib—PDPK1—Costimulation by the CD28 family—CTLA4—Graves' disease	0.0019	0.0159	CbGpPWpGaD
Celecoxib—PDPK1—TCR signaling in naïve CD8+ T cells—CD8A—Graves' disease	0.00179	0.0149	CbGpPWpGaD
Celecoxib—PDPK1—Downstream TCR signaling—HLA-DRB1—Graves' disease	0.00179	0.0149	CbGpPWpGaD
Celecoxib—Vomiting—Propylthiouracil—Graves' disease	0.00177	0.00841	CcSEcCtD
Celecoxib—CA4—thyroid gland—Graves' disease	0.00177	0.0223	CbGeAlD
Celecoxib—Rash—Propylthiouracil—Graves' disease	0.00176	0.00834	CcSEcCtD
Celecoxib—Dermatitis—Propylthiouracil—Graves' disease	0.00176	0.00833	CcSEcCtD
Celecoxib—PDPK1—TCR signaling—HLA-DQB1—Graves' disease	0.00176	0.0146	CbGpPWpGaD
Celecoxib—Headache—Propylthiouracil—Graves' disease	0.00175	0.00829	CcSEcCtD
Celecoxib—PDPK1—G beta:gamma signalling through PI3Kgamma—IL2RA—Graves' disease	0.00174	0.0145	CbGpPWpGaD
Celecoxib—PDPK1—GPVI-mediated activation cascade—IL2RA—Graves' disease	0.00171	0.0143	CbGpPWpGaD
Celecoxib—CA2—pituitary gland—Graves' disease	0.0017	0.0215	CbGeAlD
Celecoxib—CA2—adipose tissue—Graves' disease	0.00169	0.0214	CbGeAlD
Celecoxib—MAPK14—CD40/CD40L signaling—CD40—Graves' disease	0.00167	0.0139	CbGpPWpGaD
Celecoxib—PDPK1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00167	0.0139	CbGpPWpGaD
Celecoxib—PDPK1—G-protein beta:gamma signalling—IL2RA—Graves' disease	0.00166	0.0138	CbGpPWpGaD
Celecoxib—Nausea—Propylthiouracil—Graves' disease	0.00166	0.00786	CcSEcCtD
Celecoxib—PTGS2—connective tissue—Graves' disease	0.00163	0.0206	CbGeAlD
Celecoxib—PDPK1—Interleukin-11 Signaling Pathway—ICAM1—Graves' disease	0.00162	0.0135	CbGpPWpGaD
Celecoxib—PDPK1—TCR signaling in naïve CD8+ T cells—HLA-A—Graves' disease	0.00159	0.0133	CbGpPWpGaD
Celecoxib—PDPK1—Costimulation by the CD28 family—HLA-DQB1—Graves' disease	0.00157	0.0131	CbGpPWpGaD
Celecoxib—CA2—thyroid gland—Graves' disease	0.00146	0.0185	CbGeAlD
Celecoxib—MAPK14—CXCR3-mediated signaling events—CXCL10—Graves' disease	0.00143	0.0119	CbGpPWpGaD
Celecoxib—MAPK14—TSH signaling pathway—TSHR—Graves' disease	0.00142	0.0118	CbGpPWpGaD
Celecoxib—PDPK1—TCR signaling—HLA-DRB1—Graves' disease	0.00133	0.0111	CbGpPWpGaD
Celecoxib—PDPK1—Neuronal System—GABRA3—Graves' disease	0.00128	0.0107	CbGpPWpGaD
Celecoxib—PDPK1—Downstream TCR signaling—CD4—Graves' disease	0.00126	0.0105	CbGpPWpGaD
Celecoxib—PTGS2—pituitary gland—Graves' disease	0.00125	0.0158	CbGeAlD
Celecoxib—PTGS2—adipose tissue—Graves' disease	0.00125	0.0158	CbGeAlD
Celecoxib—PDPK1—TCR signaling in naïve CD4+ T cells—HLA-DRB1—Graves' disease	0.00122	0.0102	CbGpPWpGaD
Celecoxib—MAPK14—FAS (CD95) signaling pathway—FASLG—Graves' disease	0.00122	0.0101	CbGpPWpGaD
Celecoxib—PDPK1—Costimulation by the CD28 family—HLA-DRB1—Graves' disease	0.00119	0.00993	CbGpPWpGaD
Celecoxib—MAPK14—FAS (CD95) signaling pathway—FAS—Graves' disease	0.00117	0.00978	CbGpPWpGaD
Celecoxib—PDPK1—TCR Signaling Pathway—CD8A—Graves' disease	0.00117	0.00975	CbGpPWpGaD
Celecoxib—PDPK1—TCR Signaling Pathway—FAS—Graves' disease	0.00106	0.00884	CbGpPWpGaD
Celecoxib—PDPK1—CXCR4-mediated signaling events—HLA-DRB1—Graves' disease	0.00101	0.00839	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 signaling—HLA-E—Graves' disease	0.000977	0.00814	CbGpPWpGaD
Celecoxib—PDPK1—TCR signaling—CD4—Graves' disease	0.000941	0.00785	CbGpPWpGaD
Celecoxib—MAPK14—TSLP Signaling Pathway—IL2RA—Graves' disease	0.000921	0.00768	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 interactions—HLA-E—Graves' disease	0.000919	0.00766	CbGpPWpGaD
Celecoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—Graves' disease	0.000903	0.00753	CbGpPWpGaD
Celecoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Graves' disease	0.000866	0.00722	CbGpPWpGaD
Celecoxib—PDPK1—TCR signaling in naïve CD4+ T cells—CD4—Graves' disease	0.000861	0.00718	CbGpPWpGaD
Celecoxib—MAPK14—IL12-mediated signaling events—CD8A—Graves' disease	0.00084	0.00701	CbGpPWpGaD
Celecoxib—PDPK1—Costimulation by the CD28 family—CD4—Graves' disease	0.00084	0.00701	CbGpPWpGaD
Celecoxib—MAPK14—IL2-mediated signaling events—IL2RA—Graves' disease	0.000824	0.00687	CbGpPWpGaD
Celecoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Graves' disease	0.000808	0.00674	CbGpPWpGaD
Celecoxib—MAPK14—IL12-mediated signaling events—FASLG—Graves' disease	0.00079	0.00659	CbGpPWpGaD
Celecoxib—MAPK14—IL12-mediated signaling events—IL2RA—Graves' disease	0.000758	0.00632	CbGpPWpGaD
Celecoxib—MAPK14—IL12-mediated signaling events—HLA-A—Graves' disease	0.000749	0.00625	CbGpPWpGaD
Celecoxib—MAPK14—Monoamine Transport—IL1B—Graves' disease	0.000737	0.00615	CbGpPWpGaD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.000725	0.00605	CbGpPWpGaD
Celecoxib—PDPK1—CXCR4-mediated signaling events—CD4—Graves' disease	0.00071	0.00592	CbGpPWpGaD
Celecoxib—MAPK14—RANKL/RANK Signaling Pathway—ICAM1—Graves' disease	0.000704	0.00587	CbGpPWpGaD
Celecoxib—MAPK14—Thromboxane A2 receptor signaling—ICAM1—Graves' disease	0.000694	0.00579	CbGpPWpGaD
Celecoxib—MAPK14—IL12-mediated signaling events—HLA-DRB1—Graves' disease	0.000684	0.00571	CbGpPWpGaD
Celecoxib—PDPK1—TCR Signaling Pathway—CD4—Graves' disease	0.000672	0.0056	CbGpPWpGaD
Celecoxib—PDPK1—Cardiac Hypertrophic Response—TNF—Graves' disease	0.000667	0.00556	CbGpPWpGaD
Celecoxib—PDPK1—DAP12 interactions—HLA-B—Graves' disease	0.000655	0.00546	CbGpPWpGaD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.000648	0.00541	CbGpPWpGaD
Celecoxib—PDPK1—TCR Signaling Pathway—IL1B—Graves' disease	0.00062	0.00517	CbGpPWpGaD
Celecoxib—MAPK14—p73 transcription factor network—FAS—Graves' disease	0.000611	0.0051	CbGpPWpGaD
Celecoxib—MAPK14—TCR Signaling Pathway—CD8A—Graves' disease	0.000608	0.00507	CbGpPWpGaD
Celecoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.000584	0.00487	CbGpPWpGaD
Celecoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Graves' disease	0.000571	0.00476	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.000566	0.00472	CbGpPWpGaD
Celecoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.00056	0.00467	CbGpPWpGaD
Celecoxib—MAPK14—TCR Signaling Pathway—FAS—Graves' disease	0.000551	0.00459	CbGpPWpGaD
Celecoxib—CA14—Metabolism—GC—Graves' disease	0.000549	0.00458	CbGpPWpGaD
Celecoxib—MAPK14—IL2-mediated signaling events—IFNG—Graves' disease	0.000544	0.00453	CbGpPWpGaD
Celecoxib—CA6—Metabolism—GC—Graves' disease	0.000535	0.00446	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—GC—Graves' disease	0.000535	0.00446	CbGpPWpGaD
Celecoxib—MAPK14—Monoamine Transport—TNF—Graves' disease	0.000535	0.00446	CbGpPWpGaD
Celecoxib—PTGS2—Overview of nanoparticle effects—TNF—Graves' disease	0.000519	0.00432	CbGpPWpGaD
Celecoxib—PDPK1—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000514	0.00428	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—ICAM1—Graves' disease	0.000512	0.00427	CbGpPWpGaD
Celecoxib—MAPK14—ATF-2 transcription factor network—IFNG—Graves' disease	0.000507	0.00422	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.000506	0.00422	CbGpPWpGaD
Celecoxib—MAPK14—IL12-mediated signaling events—IFNG—Graves' disease	0.0005	0.00417	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—GC—Graves' disease	0.000499	0.00416	CbGpPWpGaD
Celecoxib—MAPK14—IL12-mediated signaling events—CD4—Graves' disease	0.000483	0.00402	CbGpPWpGaD
Celecoxib—MAPK14—IL-1 signaling pathway—IL1B—Graves' disease	0.000478	0.00398	CbGpPWpGaD
Celecoxib—PDPK1—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.000476	0.00396	CbGpPWpGaD
Celecoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TNF—Graves' disease	0.000466	0.00389	CbGpPWpGaD
Celecoxib—CA12—Metabolism—GC—Graves' disease	0.000463	0.00386	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—IFIH1—Graves' disease	0.000454	0.00378	CbGpPWpGaD
Celecoxib—MAPK14—IL12-mediated signaling events—IL1B—Graves' disease	0.000446	0.00372	CbGpPWpGaD
Celecoxib—MAPK14—TWEAK Signaling Pathway—TNF—Graves' disease	0.00043	0.00359	CbGpPWpGaD
Celecoxib—CA14—Metabolism—B3GNT2—Graves' disease	0.000416	0.00347	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000408	0.0034	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—B3GNT2—Graves' disease	0.000405	0.00338	CbGpPWpGaD
Celecoxib—CA6—Metabolism—B3GNT2—Graves' disease	0.000405	0.00338	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—IFNG—Graves' disease	0.000389	0.00325	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.000387	0.00322	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—B3GNT2—Graves' disease	0.000378	0.00316	CbGpPWpGaD
Celecoxib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—TNF—Graves' disease	0.000374	0.00312	CbGpPWpGaD
Celecoxib—MAPK14—Leptin signaling pathway—IL1B—Graves' disease	0.000373	0.00311	CbGpPWpGaD
Celecoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000369	0.00308	CbGpPWpGaD
Celecoxib—CA4—Metabolism—GC—Graves' disease	0.000369	0.00308	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—CXCL10—Graves' disease	0.000369	0.00307	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—HLA-E—Graves' disease	0.000357	0.00298	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GC—Graves' disease	0.000354	0.00295	CbGpPWpGaD
Celecoxib—CA12—Metabolism—B3GNT2—Graves' disease	0.000351	0.00292	CbGpPWpGaD
Celecoxib—MAPK14—TCR Signaling Pathway—CD4—Graves' disease	0.000349	0.00291	CbGpPWpGaD
Celecoxib—MAPK14—Cardiac Hypertrophic Response—TNF—Graves' disease	0.000347	0.00289	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—FASLG—Graves' disease	0.000347	0.00289	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HLA-E—Graves' disease	0.000343	0.00286	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—TSHR—Graves' disease	0.000339	0.00282	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CD40—Graves' disease	0.000335	0.00279	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—FAS—Graves' disease	0.000334	0.00279	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CTLA4—Graves' disease	0.00033	0.00275	CbGpPWpGaD
Celecoxib—MAPK14—TCR Signaling Pathway—IL1B—Graves' disease	0.000322	0.00269	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—IFNG—Graves' disease	0.000319	0.00266	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—ICAM1—Graves' disease	0.000315	0.00262	CbGpPWpGaD
Celecoxib—PDPK1—Disease—B3GNT2—Graves' disease	0.000313	0.00261	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000313	0.00261	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000309	0.00258	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—TSHR—Graves' disease	0.000308	0.00257	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000305	0.00254	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000302	0.00252	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GC—Graves' disease	0.000298	0.00249	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—IFNG—Graves' disease	0.000294	0.00245	CbGpPWpGaD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	0.000292	0.00243	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—IL1B—Graves' disease	0.000285	0.00238	CbGpPWpGaD
Celecoxib—CA4—Metabolism—B3GNT2—Graves' disease	0.00028	0.00233	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000272	0.00227	CbGpPWpGaD
Celecoxib—CA2—Metabolism—B3GNT2—Graves' disease	0.000268	0.00223	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000267	0.00223	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—IL2RA—Graves' disease	0.000265	0.00221	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IFIH1—Graves' disease	0.000264	0.0022	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—IL1B—Graves' disease	0.000262	0.00219	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000258	0.00215	CbGpPWpGaD
Celecoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000256	0.00213	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—HLA-B—Graves' disease	0.000254	0.00212	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CD8A—Graves' disease	0.000254	0.00212	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—ICAM1—Graves' disease	0.00025	0.00208	CbGpPWpGaD
Celecoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.000247	0.00206	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HLA-B—Graves' disease	0.000244	0.00204	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—ICAM1—Graves' disease	0.000244	0.00204	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—IFNG—Graves' disease	0.000239	0.002	CbGpPWpGaD
Celecoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000239	0.00199	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IFIH1—Graves' disease	0.000236	0.00197	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—CD4—Graves' disease	0.000236	0.00196	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—IFNG—Graves' disease	0.000235	0.00196	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.000228	0.0019	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HLA-A—Graves' disease	0.000226	0.00189	CbGpPWpGaD
Celecoxib—CA9—Metabolism—B3GNT2—Graves' disease	0.000226	0.00188	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CXCL10—Graves' disease	0.000219	0.00183	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—IL1B—Graves' disease	0.000214	0.00178	CbGpPWpGaD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000212	0.00176	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—IL1B—Graves' disease	0.00021	0.00175	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000209	0.00174	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HLA-E—Graves' disease	0.000208	0.00173	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000207	0.00172	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD40—Graves' disease	0.000203	0.00169	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CTLA4—Graves' disease	0.0002	0.00167	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.0002	0.00167	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CXCL10—Graves' disease	0.000199	0.00166	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—ICAM1—Graves' disease	0.000198	0.00165	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—IL1B—Graves' disease	0.000196	0.00163	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000193	0.00161	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—TNF—Graves' disease	0.00019	0.00159	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IFNG—Graves' disease	0.00019	0.00159	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IFNG—Graves' disease	0.000186	0.00155	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—HLA-E—Graves' disease	0.000186	0.00155	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000185	0.00154	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TSHR—Graves' disease	0.000182	0.00152	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000171	0.00142	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IL1B—Graves' disease	0.00017	0.00141	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—IL2RA—Graves' disease	0.000167	0.0014	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL1B—Graves' disease	0.000166	0.00138	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000165	0.00138	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HLA-DQB1—Graves' disease	0.000165	0.00138	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—IL2RA—Graves' disease	0.000157	0.00131	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TNF—Graves' disease	0.000155	0.00129	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD8A—Graves' disease	0.000154	0.00128	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—TNF—Graves' disease	0.000152	0.00127	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL2RA—Graves' disease	0.000152	0.00127	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—CD4—Graves' disease	0.000152	0.00127	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HLA-B—Graves' disease	0.000148	0.00124	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CD4—Graves' disease	0.000146	0.00122	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TNF—Graves' disease	0.000142	0.00118	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL2RA—Graves' disease	0.000139	0.00116	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000138	0.00115	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IL2RA—Graves' disease	0.000138	0.00115	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFIH1—Graves' disease	0.000137	0.00115	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HLA-A—Graves' disease	0.000137	0.00114	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—HLA-B—Graves' disease	0.000132	0.0011	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000128	0.00107	CbGpPWpGaD
Celecoxib—PDPK1—Disease—HLA-A—Graves' disease	0.000127	0.00106	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HLA-DRB1—Graves' disease	0.000125	0.00105	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—TNF—Graves' disease	0.000123	0.00103	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—ICAM1—Graves' disease	0.00012	0.001	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TNF—Graves' disease	0.00012	0.001	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CXCL10—Graves' disease	0.000117	0.000979	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GC—Graves' disease	0.000115	0.000958	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-E—Graves' disease	0.000108	0.000901	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD40—Graves' disease	0.000106	0.000881	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CTLA4—Graves' disease	0.000104	0.000868	CbGpPWpGaD
Celecoxib—PTGS2—Disease—B3GNT2—Graves' disease	0.000104	0.000867	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TSHR—Graves' disease	9.45e-05	0.000787	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GC—Graves' disease	9.3e-05	0.000775	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IFNG—Graves' disease	9.16e-05	0.000764	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL2RA—Graves' disease	8.98e-05	0.000748	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD4—Graves' disease	8.85e-05	0.000738	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—B3GNT2—Graves' disease	8.71e-05	0.000726	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DQB1—Graves' disease	8.57e-05	0.000715	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	8.18e-05	0.000682	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL1B—Graves' disease	8.17e-05	0.000681	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CD4—Graves' disease	8.17e-05	0.000681	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD8A—Graves' disease	8e-05	0.000667	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CD4—Graves' disease	7.89e-05	0.000658	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-B—Graves' disease	7.7e-05	0.000642	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GC—Graves' disease	7.68e-05	0.00064	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GC—Graves' disease	7.61e-05	0.000634	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2RA—Graves' disease	7.22e-05	0.000602	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-A—Graves' disease	7.13e-05	0.000595	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2RA—Graves' disease	7.11e-05	0.000593	CbGpPWpGaD
Celecoxib—ALB—Metabolism—B3GNT2—Graves' disease	7.05e-05	0.000587	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DRB1—Graves' disease	6.52e-05	0.000543	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ICAM1—Graves' disease	6.26e-05	0.000522	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL10—Graves' disease	6.1e-05	0.000509	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—Graves' disease	5.99e-05	0.000499	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—B3GNT2—Graves' disease	5.82e-05	0.000485	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—B3GNT2—Graves' disease	5.77e-05	0.000481	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GC—Graves' disease	5.02e-05	0.000418	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNG—Graves' disease	4.76e-05	0.000397	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2RA—Graves' disease	4.67e-05	0.000389	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD4—Graves' disease	4.6e-05	0.000383	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1B—Graves' disease	4.25e-05	0.000354	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HLA-A—Graves' disease	4.21e-05	0.000351	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—B3GNT2—Graves' disease	3.8e-05	0.000317	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD4—Graves' disease	2.71e-05	0.000226	CbGpPWpGaD
